• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI CAPSUREFIX LEAD; PERMANENT PACEMAKER ELECTRODE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI CAPSUREFIX LEAD; PERMANENT PACEMAKER ELECTRODE Back to Search Results
Model Number 5568-53
Device Problems High impedance (1291); Connection Problem (2900); Impedance Problem (2950); High Capture Threshold (3266)
Patient Problems Dyspnea (1816); Fatigue (1849); Dizziness (2194); Anxiety (2328); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/21/2023
Event Type  Injury  
Event Description
It was reported that the right atrial (ra) lead exhibited high and undefined impedance in addition to high thresholds.It was noted that there is a possible header/connection issue with the cardiac resynchronization therapy defibrillator (crt-d).The ra lead and crt-d remain in use. no patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Product event summary: the lead was not returned for analysis, however, performance data collected from the device was received and analyzed.Analysis of the device memory indicated the impedance of the atrial pacing lead was beyond the expected upper range.Analysis of the device memory indicated atrial pacing capture threshold was elevated.Continuation of d10: dtpa2d1 crt-d, implanted (b)(6)2023 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Correction: h6: device codes (fdd/annex a: a12).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was later reported by the patient that they were not feeling right within one week of implant of the new crt-d.The patient was feeling lightheaded, dizzy, and became fatigued fairly easily.The patient had never experienced the symptoms before.Everything checked out fine prior to the implant of the new crt-d.The patient could previously walk up multiple flights of stairs but was now tired and out of breath after one flight.The patient was afraid to go on walks for fear of passing out.The patient reported that at a post-operative check, it was found that the lead was disconnected or was not making contact with the crt-d and impedance measurements were changing.The patient's physician reportedly did not appear concerned about the disconnected lead and instead opted to change the patient's heart failure medication.The patient's symptoms have not changed since.They still get fatigued, dizzy, and lightheaded even with normal activity like getting up from the couch.The patient's physician had spoken to them about pacemaker syndrome with which the patient felt their symptoms aligned.The patient's main concern was a defect with the crt-d or lead.No further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPSUREFIX LEAD
Type of Device
PERMANENT PACEMAKER ELECTRODE
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer (Section G)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key17140660
MDR Text Key317335058
Report Number2649622-2023-15419
Device Sequence Number1
Product Code DTB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P930039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/15/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/12/2008
Device Model Number5568-53
Device Catalogue Number5568-53
Was Device Available for Evaluation? No
Date Manufacturer Received01/31/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/12/2006
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
694765 LEAD, 419388 LEAD
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexMale
-
-